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Background.There is a little published data regarding the association between salt intake and albuminuria as an important alarm for
progression of cardiovascular and renal dysfunction.We aimed to assess this relationship to emphasize the major role of restricting
salt intake to minimize albuminuria and prevent these life-threatening events. Methods. The study population comprised 820
individuals. Participants were assigned to groups as follows: normal albuminuria, slight albuminuria, and clinical albuminuria.
Daily salt intake was assessed on the basis of 24-hour urinary sodium excretion, since urinary sodium excretion largely equals
sodium intake. Results. In normotensive participants, the mean level of urine albumin was higher in those who had higher amounts
of salt intakewith a significantly upward trend (themean urinary albumin level in low-salt-diet group, inmedium-salt-intake group,
and in high-salt-intake group was 42.70±36.42, 46.89±38.91, and 53.38±48.23, resp., (𝑃 = 0.017)).There was a significant positive
correlation between 24-hour urinary sodium secretion and the level of urine albumin (beta = 0.130, 𝑃 < 0.001). The amount of salt
intake was significantly associated with urine albumin concentration (beta = 3.969, SE = 1.671, 𝑃 = 0.018). Conclusion. High salt
intake was shown to be associated with higher level of microalbuminuria even adjusted for potential underlying risk factors.
1. Introduction
Control of dietary intake and its main components is a main
and essential strategy to prevent progression of cardiovas-
cular disorders as left ventricular hypertrophy and kidney
diseases as renal fibrosis. In this regard, slowing progression
of renal diseases forward to end stages is obtained by proper
control of blood pressure and its regulative mechanisms. In
this regard and because of the partially low efficacy of medi-
cations to present kidney disease progression, dietary behav-
ioral modification can play a major role in this goal [1, 2]. For
decades, association between salt intake and blood pressure
has been discussed, and it has been shown that the increase
of salt intake contributes to the prevalence of hypertension.
However, relationship between high salt intake and albumin-
uria has been already questioned [3, 4].
Although albuminuria is not a usual finding in general
population, according to the Third National Health and
Examination Survey (NHANES III) [5], about 7.8% of indi-
viduals suffered from this abnormal phenomenon so that it
frequently appeared in higher risk groups including diabetics
and hypertensive patients. In addition, those withmicroalbu-
minuria are at the greatest risk for progression to both cardio-
vascular and renal events [6]. Recently, it has been shown that
the reducing proteinuria is associated with a reduction in
both renal and cardiovascular events [7]. Besides, it is now
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Table 1: Baseline characteristics and clinical data of study population.
Characteristics low-salt-intake(𝑛 = 273)
med-salt-intake
(𝑛 = 271)
high-salt-intake
(𝑛 = 276) 𝑃 value
Male gender 190 (69.6) 137 (50.6) 130 (47.1) <0.001
Age, yr 38.78 ± 14.00 35.88 ± 11.51 37.07 ± 11.97 0.029
Body mass intake (kg/m2) 24.93 ± 4.22 25.10 ± 4.56 26.43 ± 4.25 <0.001
Waist circumference (cm) 80.60 ± 11.44 82.04 ± 11.93 85.15 ± 12.45 <0.001
Current smoker 25 (9.4) 29 (11.3) 22 (8.5) 0.156
History of hypertension 23 (8.4) 17 (6.3) 34 (12.3) 0.060
Systolic PB, mmHg 106.71 ± 12.82 105.83 ± 12.56 107.45 ± 13.67 0.351
Diastolic BP, mmHg 71.23 ± 9.36 70.54 ± 9.55 72.34 ± 10.68 0.101
Serum BUN level 15.31 ± 3.37 15.21 ± 3.55 15.12 ± 3.73 0.812
Serum creatinine level 0.94 ± 0.17 0.98 ± 0.23 0.98 ± 0.21 0.052
Serum sodium level 138.96 ± 3.12 139.11 ± 3.22 139.25 ± 3.23 0.551
Urine creatinine level 119.24 ± 46.61 133.82 ± 44.21 145.66 ± 49.54 <0.001
Urine albumin 43.07 ± 37.48 46.55 ± 38.18 53.56 ± 47.60 0.011
clear that reducing dietary salt consumption can be consider
as a potentiallymodifiable risk thatmay protect patients from
cardiovascular and renal disease progression [8]. However, to
date, there have been a few syntheses of the existing evidence
regarding the association between salt intake and albumin-
uria as an important alarm for progression of cardiovascular
and renal dysfunction.Therefore, we aimed to assess this rela-
tionship to emphasize the major role of restricting salt intake
to minimize albuminuria and prevent these life-threatening
events.
2. Methods
The study population comprised 820 normotensive individ-
uals (457 men and 363 women), ages 19–81 years (median
35 years) who participated in an Isfahan, Iran population-
based survey [2]. All participants gave informed consent,
and procedures followed were in accordance with the Eth-
ical Committee of Isfahan University of Medical Sciences.
Baseline information regarding demographics, educational
level, medical history, andmedications was recorded. Height,
weight and waist circumference were measured on the day of
the visit to the outpatient clinic. Body mass index (BMI) was
calculated as weight was divided by height squared (kg/m2).
Blood pressure was measured twice in the left arm by an
examining physician using a mercury column sphygmo-
manometer (Korotkoff phases I and V) after the subject had
been at rest in the seated position for 5minutes.Hypertension
was defined as a systolicblood pressure (SBP) of ≥140mmHg,
a diastolic blood pressure (DBP) of ≥90mmHg, or those who
were receiving antihypertensive therapy at the time of the
examination [4]. Smoking status was also considered as
smoking ≥1 cigarette per day in the year preceding the exam-
ination. Participants fasted from the evening before the inter-
view, and on the day of interview a first voided urine sample
was collected into a sterile container for albumin estima-
tion. Blood was also drawn after an 8–12 overnight fasting
period in the morning after completion of the 24-hour urine
collection. Plasma biochemical indices including sodium
and potassium concentrations, as well as BUN and serum
creatinine levels were measured by standard laboratory pro-
cedures. Urinary albumin concentrations were determined
by immunoturbidixnetric assay, and the participants were
assigned to groups as follows: normal albuminuria (men ≤
28mg/L, women ≤ 29mg/L); slight albuminuria (men 29–
299mg/L, women 30–299mg/L); and clinical albuminuria
(≥300mg/L) [9]. Daily salt intake was assessed on the basis of
24-hour urinary sodium excretion (UNaV), since urinary
sodium excretion largely equals sodium intake, when people
are in steady state [10]. The subjects were divided into tertiles
according to the level of 24-hour urinary sodium excre-
tion: low-salt-intake group (𝑛 = 273, urine sodium ≤
132mmol/24 h), medium-salt-intake group (𝑛 = 271, urine
sodium: 133–186mmol/24 h), and high-salt-intake group
(𝑛 = 276, urine sodium ≥ 187 Bmmol/24).
Results were presented as mean ± standard deviation
(SD) for quantitative variables and summarized by absolute
frequencies and percentages for categorical variables. Contin-
uous variables were compared using 𝑡 test or one-way analysis
of variance (ANOVA) and/or nonparametric Mann-Whitney
𝑈 test or Kruskal-Wallis test whenever the data did not appear
to have normal distribution or when the assumption of equal
varianceswas violated across the three groups of TR. Categor-
ical variables were, on the other hand, compared using chi-
square test or Fisher’s exact test when more than 20% of cells
with expected count of less than 5 were observed. Correlation
between quantitative variables was assessed using Pearson’s
correlation coefficient test. For the statistical analysis, the
statistical software SPSS version 19.0 for windows (SPSS Inc.,
Chicago, IL) and the statistical package SAS version 9.1 for
windows (SAS Institute Inc., Cary, NC, USA) were used. 𝑃
values of 0.05 or less were considered statistically significant.
3. Results
Comparing baseline characteristics and clinical data across
the three groups of salt intake (Table 1) revealed that male
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Figure 1: Mean urine albumin level in different salt intake groups.
gender distribution was more in low-salt-intake group. The
participants in lower-salt intake categories were significantly
older, and had lower BMI and waist circumference. No dis-
crepancy was observed in overall prevalence of hypertension,
current smoking, and also in mean systolic and diastolic
blood pressures. Regarding laboratory indices, the average
urine creatinine level and urine albumin concentration were
both higher in those who had higher salt intake.
According to the classification of albuminuria, 42.4% of
individuals had normal range of urine albumin level, 57.4%
had slight albuminuria, and only 0.1% suffered from clini-
cal albuminuria. As presented in Figure 1, in normotensive
participants, the mean level of urine albumin was higher in
thosewho had higher amounts of salt intakewith a significant
upward (that the mean urinary albumin level in low-salt-
diet group was 42.70 ± 36.42; in medium-salt-intake group,
46.89 ± 38.91; and in high-salt-intake group, 53.38 ± 48.23
(𝑃 = 0.017)), while in this trend the changes were not sig-
nificant in hypertensive ones (mean urinary albumin level in
low-salt-diet group was 47.09 ± 38.25, in medium-salt-intake
group was 41.35 ± 24.96, and in high-salt-intake group was
54.85 ± 43.50, 𝑃 = 0.529).
There was a significant positive correlation between 24-
hour urinary sodium secretion and the level of urine albumin
(beta = 0.130,𝑃 < 0.001) (Figure 2). Using amultivariable lin-
ear regression model (Table 2) and with the presence of base-
line variables, the amount of salt intakewas significantly asso-
ciated with urine albumin concentration (beta = 3.969, SE =
1.671, 𝑃 = 0.018).
4. Discussion
Positive or inverse association between salt intake and albu-
minuria has been also unknown. Although some evidence
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Figure 2: Correlation between 24-hour urinary sodium secretion
and level of urine albumin (beta = 0.130, 𝑃 < 0.001).
Table 2: Association between salt intake and albuminuria in a linear
regression model.
Variable 𝑃 value Beta SE
Salt intake 0.018 3.969 1.671
Gender 0.649 1.384 3.040
Age 0.520 0.074 0.115
Body mass index 0.240 0.399 0.339
Hypertension 0.423 4.348 5.428
Smoking 0.002 −7.233 2.355
Systolic BP 0.139 0.291 0.196
Diastolic BP 0.321 −0.236 0.238
showed that low daily salt intake is associated with albu-
minuria in diabetic patients [11], some others showed that
high salt intake increases blood pressure and albuminuria
in diabetic patients that is associated with insulin resistance
and increased glomerular pressure [12, 13]. In the studies
on animal models, high sodium treatment led to a sig-
nificantly increased excretion of albumin in the urine of
animals compared with control animals and also animals on
normal drinking water [14]. It has been also demonstrated,
in line with increased albuminuria following high salt intake,
that the activation of inflammatory processes can occur by
increase of salt intake and that both the increase of the urinary
level of albumin and increased inflammation can trigger end-
stage renal disease [15]. Microalbuminuria is an important
alarm indicating a defected blood urine interface that may
represent a serious diffuse vascular disease throughout the
circulation [7, 8] Hence, presence of microalbuminuria can
help the clinician to identify those individuals with greater
cardiovascular and renal risk factors and a greater need for
improved other related risk profile including blood pressure,
lipids, insulin resistance, and hyperglycemia.
Our findings can be assessed through different aspects.
First, we showed a direct association between high salt intake
and the increase of albuminuria that is consistent with some
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previous observations. Also, this association was also shown
independent from other underlying risk factors such as
hypertension and smoking. Moreover, we considered only
nondiabetic patients to inhibit interactive effects of diabetes
and insulin resistance as a trigger for albuminuria.
Our results are based on this mechanism that high
sodium is harmful to the selective permeability of the glomer-
ular basement membrane and worsens the urinary excretion
of albumin [16]. It is now believed that the glomerular
podocyte in the outer layer of glomerular epithelial cells is the
cell primarily responsible for the prevention of albuminuria
in health state, and thus podocyte damages underlie albumin-
uria [17]. This tissue damage can be mediated by the secre-
tion of some inflammatory mediators such as transforming
growth factor-𝛽 (TGF-𝛽) and cytokines produced in response
to changes in systemic factors, particularly blood pressure
[18]. Besides, the increase in blood pressure during high
sodium intake can raise the activity of TGF-𝛽 and therefore
increase the urinary albumin excretion [18].This mechanism
can successfully explain our finding. However, an unusual
finding in the present study was the association between salt
intake and albuminuria only in normotensive individuals, not
in hypertensive ones that should be tested in further studies
with considering different hypertension categories, using
antihypertensive drugs and other confounding factors related
to this index.
In conclusion, high salt intake was shown to be associated
with higher level of microalbuminuria even adjusted for
potential underlying risk factors. Although this association
seems to be related to hypertension state, it may be more evi-
denced in normal blood pressure condition.
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